| My Account | Subscribe | Contact Us | Donate |
Home
- The Edmonton Protocol and Me
- Olympia Dukakis and Her Husband Tackle Type 2
- Surfing with Type 1
- Behind the Wheel, But Still in Control
You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
If you are a physician, educator and medical professional who focus on the treatment of diabetes, then this is the must have resource for you.
Finally! A fresh take on the “professional” journal. Each bi-monthly issue cuts through the jargon and presents the most important information you need to enhance your practice and assist your patients.
Each bi-monthly issue of Diabetes Health Professional is a self-contained handbook covering products, educational resources and the latest diabetes research, complimented by balanced editorial focused on medical news, drug prescription information, clinical practice recommendations and changing treatment options.
Each quarter we send you the latest, most updated research guides, product guides and educational resource guides available for you and your patients.
Each week the Diabetes Health E-Newsletter delivers links to the very latest in news, reviews, blogs and videos from Diabetes Health direct to your inbox.
As a subscriber you'll get access to the amazing Diabetes Health Digital Advantage™ so you can read the current issue of Diabetes Health magazine online wherever you are!
You can cancel your newsletter subscription at anytime by clicking "Unsubscribe" on the bottom of any newsletter you receive
Then enter your new email address in the above form and click "Subscribe"
Latest Insulin Articles
Insulin might be a good choice for adults newly diagnosed with type 2 diabetes.
Study Investigates Starting with Insulin for Newly Diagnosed Type 2
Sep 12, 2009
Adults newly diagnosed with type 2 diabetes generally don't take to the idea of using insulin right off the bat. They're worried about gaining weight and fear low blood sugars. They're also concerned about whether they can manage the regimen and fear that taking insulin will lower their quality of life. Those concerns, however, might be assuaged by a study recently conducted by Ildiko Lingvay and his colleagues at the University of Texas Southwestern.
In the study, patients with newly diagnosed type 2 diabetes were randomly assigned to one of two groups: an insulin group that received insulin and metformin, or an oral group that received metformin, pioglitazone, and glyburide. Each group spent three years on the regimen.
At the end of the study, the findings for both groups were remarkably similar. Both groups had A1c's of about 6%. Both had gained about four to seven kilograms and had experienced a similar number of hypoglycemic events. Compliance with the regimens, quality of life, and treatment satisfaction were also very similar between the groups. In fact, 100 percent of the folks in the insulin group who completed the study were willing to keep it up.
Source: Abstract, Diabetes Care
Categories: Insulin, Metformin, Research, Type 2 Issues
Facebook
MySpace 
Digg
You May Also Be Interested In...
Click Here To View Or Post Comments
5 comments -
Sep 12, 2009 -
Email to a Friend
Send a link to this page to your friends and colleagues.